Bilia AB (publ) (LON:0RQ2)
 133.79
 +0.43 (0.32%)
  At close: Oct 30, 2025
Bilia AB Revenue
Bilia AB had revenue of 9.72B SEK in the quarter ending September 30, 2025, with 8.16% growth. This brings the company's revenue in the last twelve months to 40.43B, up 3.59% year-over-year. In the year 2024, Bilia AB had annual revenue of 39.15B with 1.65% growth.
Revenue (ttm) 
 40.43B SEK
Revenue Growth 
 +3.59%
P/S Ratio 
 0.31
Revenue / Employee 
 7.27M SEK
Employees 
 5,559
Market Cap 
1.00B GBP
Revenue Chart
* This company reports financials in SEK.
Revenue History
| Fiscal Year End | Revenue | Change | Growth | 
|---|---|---|---|
| Dec 31, 2024 | 39.15B | 637.00M | 1.65% | 
| Dec 31, 2023 | 38.51B | 3.17B | 8.97% | 
| Dec 31, 2022 | 35.35B | -164.00M | -0.46% | 
| Dec 31, 2021 | 35.51B | 5.34B | 17.70% | 
| Dec 31, 2020 | 30.17B | 660.00M | 2.24% | 
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue | 
|---|---|
| Shell | 198.54B | 
| BP p.l.c. | 134.89B | 
| Unilever | 51.24B | 
| HSBC Holdings | 42.39B | 
| AstraZeneca | 41.24B | 
| Rio Tinto Group | 39.22B | 
| GSK plc | 32.17B | 
| British American Tobacco p.l.c. | 25.60B |